ArticleCancer immunology, immunotherapy : CII2023

Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study.

Wenchang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.